Identification of PRMT5 as a therapeutic target in cholangiocarcinoma. Elurbide J, Colyn L, Latasa MU, Uriarte I, et al. Gut 2024 Sep 11:gutjnl-2024-332998. doi: 10.1136/gutjnl-2024-332998.

Read + Share

Amedeo Smart

Independent Medical Education

Elurbide J, Colyn L, Latasa MU, Uriarte I, et al. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma. Gut 2024 Sep 11:gutjnl-2024-332998. doi: 10.1136/gutjnl-2024-332998.
PMID: 39266051